Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts

被引:551
|
作者
Astor, Brad C. [1 ]
Matsushita, Kunihiro [1 ]
Gansevoort, Ron T. [2 ]
van der Velde, Marije [2 ]
Woodward, Mark [3 ]
Levey, Andrew S. [4 ]
de Jong, Paul E. [2 ]
Coresh, Josef [1 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands
[3] Univ Sydney, George Inst, Sydney, NSW 2006, Australia
[4] Tufts Med Ctr, Div Nephrol, Boston, MA USA
关键词
albuminuria; chronic kidney disease; epidemiology; outcomes; CARDIOVASCULAR RISK; PROGRESSION; OUTCOMES; CKD;
D O I
10.1038/ki.2010.550
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
We studied here the independent associations of estimated glomerular filtration rate (eGFR) and albuminuria with mortality and end-stage renal disease (ESRD) in individuals with chronic kidney disease (CKD). We performed a collaborative meta-analysis of 13 studies totaling 21,688 patients selected for CKD of diverse etiology. After adjustment for potential confounders and albuminuria, we found that a 15 ml/min per 1.73 m(2) lower eGFR below a threshold of 45 ml/min per 1.73 m(2) was significantly associated with mortality and ESRD (pooled hazard ratios (HRs) of 1.47 and 6.24, respectively). There was significant heterogeneity between studies for both HR estimates. After adjustment for risk factors and eGFR, an eightfold higher albumin-or protein-to-creatinine ratio was significantly associated with mortality (pooled HR 1.40) without evidence of significant heterogeneity and with ESRD (pooled HR 3.04), with significant heterogeneity between HR estimates. Lower eGFR and more severe albuminuria independently predict mortality and ESRD among individuals selected for CKD, with the associations stronger for ESRD than for mortality. Thus, these relationships are consistent with CKD stage classifications based on eGFR and suggest that albuminuria provides additional prognostic information among individuals with CKD. Kidney International (2011) 79, 1331-1340; doi:10.1038/ki.2010.550; published online 2 February 2011
引用
收藏
页码:1331 / 1340
页数:10
相关论文
共 50 条
  • [11] Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis
    Nitsch, Dorothea
    Grams, Morgan
    Sang, Yingying
    Black, Corri
    Cirillo, Massimo
    Djurdjev, Ognjenka
    Iseki, Kunitoshi
    Jassal, Simerjot K.
    Kimm, Heejin
    Kronenberg, Florian
    Oien, Cecilia M.
    Levey, Andrew S.
    Levin, Adeera
    Woodward, Mark
    Hemmelgarn, Brenda R.
    BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
  • [12] Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease
    Perkins, Robert M.
    Kirchner, H. Lester
    Hartle, James E.
    Bucaloiu, Ion D.
    CLINICAL NEPHROLOGY, 2013, 80 (04) : 256 - 262
  • [13] Risk of end-stage renal disease in Japanese patients with chronic kidney disease increases proportionately to decline in estimated glomerular filtration rate
    Matsushita, Kunihiro
    Chen, Jingsha
    Sang, Yingying
    Ballew, Shoshana H.
    Shimazaki, Ryutaro
    Fukagawa, Masafumi
    Imai, Enyu
    Coresh, Josef
    Hishida, Akira
    KIDNEY INTERNATIONAL, 2016, 90 (05) : 1109 - 1114
  • [14] Annual variation of estimated glomerular filtration rate in health check-ups associated with end-stage kidney disease
    Okada, Sadanori
    Nishioka, Yuichi
    Kanaoka, Koshiro
    Koizumi, Miyuki
    Kamitani, Fumika
    Nakajima, Hiroki
    Kurematsu, Yukako
    Kubo, Sinichiro
    Myojin, Tomoya
    Noda, Tatsuya
    Saito, Yoshihiko
    Imamura, Tomoaki
    Takahashi, Yutaka
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [15] Evaluation of glomerular filtration rate in end-stage renal disease patients
    Caprio, Francesca
    Grassi, Giulia
    Barsotti, Giuliano
    Donadio, Carlo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 68 - 68
  • [16] Sofosbuvir and risk of estimated glomerular filtration rate decline or end-stage renal disease in patients with renal impairment
    Sulkowski, Mark
    Telep, Laura E.
    Colombo, Massimo
    Durand, Francois
    Reddy, K. Rajender
    Lawitz, Eric
    Bourliere, Marc
    Cheinquer, Nelson
    Scherbakovsky, Stacey
    Ni, Liyun
    Force, Lindsey
    Ramroth, Heribert
    Gaggar, Anuj
    Chokkalingam, Anand P.
    Sise, Meghan E.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (09) : 1169 - 1178
  • [17] Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts
    Gansevoort, Ron T.
    Matsushita, Kunihiro
    van der Velde, Marije
    Astor, Brad C.
    Woodward, Mark
    Levey, Andrew S.
    de Jong, Paul E.
    Coresh, Josef
    KIDNEY INTERNATIONAL, 2011, 80 (01) : 93 - 104
  • [18] Association of Intraindividual Difference in Estimated Glomerular Filtration Rate by Creatinine vs Cystatin C and End-stage Kidney Disease and Mortality
    Chen, Debbie C.
    Shlipak, Michael G.
    Scherzer, Rebecca
    Bauer, Scott R.
    Potok, O. Alison
    Rifkin, Dena E.
    Ix, Joachim H.
    Muiru, Anthony N.
    Hsu, Chi-Yuan
    Estrella, Michelle M.
    JAMA NETWORK OPEN, 2022, 5 (02)
  • [19] Estimated glomerular filtration rate decline and risk of end-stage renal disease in type 2 diabetes
    Oshima, Megumi
    Toyama, Tadashi
    Haneda, Masakazu
    Furuichi, Kengo
    Babazono, Tetsuya
    Yokoyama, Hiroki
    Iseki, Kunitoshi
    Araki, Shinichi
    Ninomiya, Toshiharu
    Hara, Shigeko
    Suzuki, Yoshiki
    Iwano, Masayuki
    Kusano, Eiji
    Moriya, Tatsumi
    Satoh, Hiroaki
    Nakamura, Hiroyuki
    Shimizu, Miho
    Hara, Akinori
    Makino, Hirofumi
    Wada, Takashi
    PLOS ONE, 2018, 13 (08):
  • [20] Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease (vol 25, pg 1753, 2019)
    Lees, Jennifer S.
    Welsh, Claire E.
    Celis-Morales, Carlos A.
    Mackay, Daniel
    Lewsey, James
    Gray, Stuart R.
    Lyall, Donald M.
    Cleland, John G.
    Gill, Jason M. R.
    Jhund, Pardeep S.
    Pell, Jill
    Sattar, Naveed
    Welsh, Paul
    Mark, Patrick B.
    NATURE MEDICINE, 2020, 26 (08) : 1308 - 1308